Correlation Between Enliven Therapeutics and Novartis
Can any of the company-specific risk be diversified away by investing in both Enliven Therapeutics and Novartis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enliven Therapeutics and Novartis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enliven Therapeutics and Novartis AG ADR, you can compare the effects of market volatilities on Enliven Therapeutics and Novartis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enliven Therapeutics with a short position of Novartis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enliven Therapeutics and Novartis.
Diversification Opportunities for Enliven Therapeutics and Novartis
-0.4 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Enliven and Novartis is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Enliven Therapeutics and Novartis AG ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novartis AG ADR and Enliven Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enliven Therapeutics are associated (or correlated) with Novartis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novartis AG ADR has no effect on the direction of Enliven Therapeutics i.e., Enliven Therapeutics and Novartis go up and down completely randomly.
Pair Corralation between Enliven Therapeutics and Novartis
Given the investment horizon of 90 days Enliven Therapeutics is expected to under-perform the Novartis. In addition to that, Enliven Therapeutics is 2.1 times more volatile than Novartis AG ADR. It trades about -0.26 of its total potential returns per unit of risk. Novartis AG ADR is currently generating about -0.31 per unit of volatility. If you would invest 11,379 in Novartis AG ADR on August 26, 2024 and sell it today you would lose (951.00) from holding Novartis AG ADR or give up 8.36% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enliven Therapeutics vs. Novartis AG ADR
Performance |
| Timeline |
| Enliven Therapeutics |
| Novartis AG ADR |
Enliven Therapeutics and Novartis Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enliven Therapeutics and Novartis
The main advantage of trading using opposite Enliven Therapeutics and Novartis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enliven Therapeutics position performs unexpectedly, Novartis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novartis will offset losses from the drop in Novartis' long position.| Enliven Therapeutics vs. Capricor Therapeutics | Enliven Therapeutics vs. Soleno Therapeutics | Enliven Therapeutics vs. Bio Path Holdings | Enliven Therapeutics vs. Moleculin Biotech |
| Novartis vs. AstraZeneca PLC ADR | Novartis vs. GlaxoSmithKline PLC ADR | Novartis vs. Roche Holding Ltd | Novartis vs. Bristol Myers Squibb |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |